TP53 and cancer: Based on the high frequency of TP53 mutations in human tumors, the oncogenic effects of many missense variants with the fact that cancer-specific pathogenic stabilization of mutant proteins effectively sustains tumor progression and dissemination, mutant p53 proteins represent indisputable promising targets in cancer therapy (17, 152).